Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Last updated: 2019
Remove filter for
Type: Alert
Clear all
Type
Audience
Category
Issue
Last updated
- (-) 2019
- December 20194 results available
- November 20192 results available
- October 20192 results available
- September 20193 results available
- July 20192 results available
- June 20192 results available
- May 20195 results available
- April 20192 results available
- March 20192 results available
- January 20191 results available
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.
Displaying 1 - 15 of 25 items.
GILENYA (fingolimod) - Risk of Congenital Malformations
Starting date:
December 19, 2019
Posting date:
December 19, 2019
Type of communication:
Dear Healthcare Professional…
AlertHealth professional risk communication | 2019-12-19
Health Canada evaluating NDMA in metformin drugs
Starting date:
December 5, 2019
Posting date:
December 5, 2019
Type of communication:
Information Update
Subcategory:
Drugs…
AlertInformation update | 2019-12-05
Health Canada clarification: laser-based medical devices are not licensed in Canada to cure fungal nail infections
Starting date:
July 25, 2019
Posting date:
December 5, 2019…
AlertInformation update | 2019-12-05
XELJANZ / XELJANZ XR (tofacitinib) - Risk of Thrombosis
Starting date:
December 2, 2019
Posting date:
December 2, 2019
Type of communication:
Dear Healthcare Professional…
AlertHealth professional risk communication | 2019-12-02
Duchesnay Inc. recalls certain lots of PregVit and PregVit folic 5 prenatal and postpartum vitamin-mineral supplements because of a packaging error
Starting date:
November 15…
AlertPublic advisory | 2019-11-15
ULORIC ® (febuxostat) - Increased Risk of Cardiovascular Fatal Outcomes
Starting date:
November 4, 2019
Posting date:
November 4, 2019
Type of communication:
Dear Healthcare…
AlertHealth professional risk communication | 2019-11-04
LEMTRADA (alemtuzumab) - Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions
Starting date:
October 15, 2019…
AlertHealth professional risk communication | 2019-10-15
Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
Starting date:
October 9, 2019
Posting date:
October 9, 2019
Type of communication:…
AlertHealth professional risk communication | 2019-10-09
RW Consumer Products Ltd. voluntarily recalls all lots of "Gripe Water – Alcohol And Preservative Free" because of microbial contamination
Starting date:
September…
AlertInformation update | 2019-09-21
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
Starting date:
September 17, 2019
Type of communication:
Information…
AlertInformation update | 2019-09-17
Needle-free dermal filler devices used for cosmetic skin treatments are not authorized in Canada and may pose health risks
Starting date:
September 13, 2019
Type of…
AlertInformation update | 2019-09-13
Health Canada clarifies position on Platelet Rich Plasma treatments
Starting date:
July 26, 2019
Type of communication:
Information Update
Subcategory:
Biologic/vaccine
Source…
AlertInformation update | 2019-07-26
Tacrolimus and the Risk of Graft Rejection due to Medication Errors: Inadvertent Switching between Different Oral Formulations…
AlertHealth professional risk communication | 2019-07-22
Substance use during summer events and festivals
Starting date:
June 20, 2019
Type of communication:
Information Update
Subcategory:
Drugs, Affects children, pregnant or…
AlertInformation update | 2019-06-20
ALERTEC (modafinil) and the Risk of Congenital Anomalies
Starting date:
June 20, 2019
Posting date:
June 20, 2019
Type of communication:
Dear Healthcare Professional Letter…
AlertHealth professional risk communication | 2019-06-20